The Rising Tide Foundation for Clinical Cancer Research ACCESS Award supports affordable, scalable interventions that improve cancer treatment and access, particularly in low- and middle-income countries. Projects may explore AI tools, drug repurposing or dose optimization, with clear potential for clinical implementation and patient benefit.
Eligibility Criteria
- Open to academic institutions, nonprofit organizations and consortia.
- International collaborations involving centers in low- and middle-income countries are strongly preferred.
- Patient partners must hold active project governance roles.
- Proposals should demonstrate clinical relevance, cost-effectiveness and scalability. Rising Tide Foundation
Funding Details
- Up to $500,000 per award, covering 50% of total project costs.
- Duration: Up to five years.
- Applicants must secure the remaining 50% co-funding, confirmed within six months of approval.
Deadline
- Letter of Intent: March 1, 2027.
- Invited full proposal: April 30, 2027.
- Award notification: August 2027.